Brief: IGM Biosciences Q4 Net Income USD -60.695 Million
07/03/2024 21:10
Mar 07 (Reuters) - IGM Biosciences Q4 basic EPS USD -1.01. * Q4 pretax profit USD -60.453 million * Q4 operating expenses USD 65.77 million * Q4 operating income USD -65.119 million * Q4 collaboration revenue USD 651 thousand
Recent news on IGM Biosciences
See all newsU.S. STOCKS ON THE MOVE-Energy stocks, Apple, Vertex
U.S. STOCKS ON THE MOVE-Snap, Solventum, GlobalFoundries
IGM Biosciences rises on buyout deal with Concentra Biosciences
Brief: Igm Biosciences Enters Into Agreement To Be Acquired By Concentra Biosciences For $1.247 In Cash Per Share Plus A Contingent Value Right
IGM Biosciences Inc reports results for the quarter ended March 31 - Earnings Summary